当前位置:首页 - 行情中心 - 济川药业(600566) - 财务分析

济川药业

(600566)

  

流通市值:263.81亿  总市值:264.70亿
流通股本:9.19亿   总股本:9.22亿

济川药业(600566)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润3.99亿元,每股收益0.44元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1501485.50万元,未分配利润1044192.00万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1783711.36万元,负债282225.86万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,207,498,577.636,218,642,450.83,932,057,245.532,748,717,966.21
营业总成本832,970,181.74,311,082,171.032,887,618,682.392,042,988,755.57
其他经营收益
营业利润473,047,371.892,157,753,144.211,255,128,353.42833,428,316.11
利润总额474,170,427.992,162,256,551.351,260,406,214.76849,042,833.53
净利润399,066,859.891,778,264,104.21,024,117,001.86725,285,908.9
每股收益
其他综合收益----
综合收益总额399,066,859.891,778,264,104.21,024,117,001.86725,285,908.9
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计14,216,926,102.914,180,194,109.2312,945,450,807.2213,038,414,389.85
非流动资产:
非流动资产合计3,620,187,487.253,520,064,388.123,588,080,734.593,637,620,941.8
资产总计17,837,113,590.1517,700,258,497.3516,533,531,541.8116,676,035,331.65
流动负债:
流动负债合计2,604,839,843.222,875,767,092.772,431,672,741.262,948,868,339.35
非流动负债:
非流动负债合计217,418,758.89191,832,597.94244,094,172.91195,227,324.53
负债合计2,822,258,602.113,067,599,690.712,675,766,914.173,144,095,663.88
所有者权益(或股东权益):
归属于母公司股东权益合计14,988,820,535.0314,605,549,345.9613,829,413,055.7113,504,319,773.11
股东权益合计15,014,854,988.0414,632,658,806.6413,857,764,627.6413,531,939,667.77
负债和股东权益合计17,837,113,590.1517,700,258,497.3516,533,531,541.8116,676,035,331.65
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,496,748,895.716,756,669,077.455,278,586,814.383,989,642,612.47
经营活动现金流出小计1,616,409,196.995,558,374,833.554,575,075,444.983,017,168,261.14
经营活动产生的现金流量净额880,339,698.721,198,294,243.9703,511,369.4972,474,351.33
投资活动产生的现金流量:
投资活动现金流入小计1,480,767,569.435,713,804,410.794,458,764,474.943,266,782,433.49
投资活动现金流出小计4,031,682,460.086,690,058,707.045,021,530,152.234,242,820,725.86
投资活动产生的现金流量净额-2,550,914,890.65-976,254,296.25-562,765,677.29-976,038,292.37
筹资活动产生的现金流量:
筹资活动现金流入小计832,822,965.061,455,807,420.31763,658,197.31449,105,850.68
筹资活动现金流出小计672,696,016.922,908,076,555.92,443,868,329.632,368,488,154.1
筹资活动产生的现金流量净额160,126,948.14-1,452,269,135.59-1,680,210,132.32-1,919,382,303.42
汇率变动对现金及现金等价物的影响-10,367.13-9,939.83-103.35
现金及现金等价物净增加额-1,510,458,610.92-1,230,239,127.77-1,539,464,440.21-1,922,946,141.11
期末现金及现金等价物余额3,928,665,005.025,439,123,615.945,129,898,303.54,746,416,602.6
补充资料:
现金及现金等价物的净增加额--1,230,239,127.77--1,922,946,141.11
最新报告期:2026-05-09
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长江证券张楠,彭英骐2.012.142.302026-05-09
国泰海通张澄,彭娉,郑琴1.912.032.172026-05-01
国投证券胡雨晴1.952.092.342026-04-29
开源证券余汝意,巢舒然1.942.102.312026-04-28
国金证券王奔奔,甘坛焕1.942.112.362026-04-23
TOP↑